An HIV-positive patient with epilepsy

被引：0

作者：

Leppik, IE ^{[1
]}

Gapany, S ^{[1
]}

Walczak, T ^{[1
]}

机构：

[1] MINCEP Epilepsy Care, Minneapolis, MN 55416 USA

来源：

EPILEPSY & BEHAVIOR | 2003年 / 4卷

关键词：

RITONAVIR; COMBINATION;

D O I：

10.1016/S1525-5050(03)00046-5

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

引用

收藏

页码：S17 / S19

页数：3

相关论文

共 4 条

[1] Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
Bertz, RJ
Granneman, GR
[J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 210 - 258
[2] Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz
Burman, W
Orr, L
[J]. AIDS, 2000, 14 (17) : 2793 - 2794
[3] Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: A case report
Cozza, KL
Swanton, EJ
Humphreys, CW
[J]. PSYCHOSOMATICS, 2000, 41 (05) : 452 - 453
[4] Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423